Global Syringe and Needle Market 2024-2028
Syringe And Needle Market 2024-2028
The syringe and needle market is forecasted to grow by USD 7352.7 mn during 2023-2028, accelerating at a CAGR of 7% during the forecast period. The report on the syringe and needle market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of critical care conditions, favorable regulations and guidelines, and increasing number of biopharmaceuticals.
Technavio's syringe and needle market is segmented as below:
By End-user
- Hospitals and clinics
- Home care
- Others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
This study identifies the innovations in pre-filled syringes as one of the prime reasons driving the syringe and needle market growth during the next few years. Also, increasing awareness about enteral feeding in critical care conditions and rising demand for syringe and needle for covid-19 vaccinations will lead to sizable demand in the market.
The report on the syringe and needle market covers the following areas:
- Syringe And Needle Market sizing
- Syringe And Needle Market forecast
- Syringe And Needle Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading syringe and needle market vendors that include Aurobindo Pharma Ltd., Avanos Medical Inc., B.Braun SE, Becton Dickinson and Co., Cardinal Health Inc., Catalent Inc., CODAN Medizinische Gerate GmbH and Co KG, GBUK Group Ltd., Gerresheimer AG, Hindustan Syringes and Medical Devices Ltd., Medela AG, Medtronic Plc, Nipro Corp., Pfizer Inc., Retractable Technologies Inc, SCHOTT AG, Smiths Group Plc, Teleflex Inc., Terumo Corp., and Thermo Fisher Scientific Inc.. Also, the syringe and needle market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.